Efficacy and Safety of Modified Gegen Qinlian Decoction for Diarrhea-predominant Irritable Boewl Syndrome

Early Phase 1

• Conditions: Diarrhea-predominant Irritable Boewl Syndrome
• Interventions: Drug: Modified Gegen Qinlian Decoction

• Registration Number: NCT04312477
• Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Brief Summary

Diarrhea-predominant irritable boewl syndrome(IBS-D) seriously affect the quality of life in patients. Clinically, it is effective to apply therapeutic method of clearing heat and promoting diuresis to the common syndrome of dampness-heat. Dysbiosis of intestinal microbiota is closely related to the immune imbalance and intestinal mucosal barrier injury. C1orf106/CYTH-1/ARF6 signal pathway, which derive from intestinal micro environment changes,is the mainly cause of intestinal mucosal barrier injury, and this is may be the common pathogenesis of dampness-heat syndrome in IBS-D . Based on the clinic, the project is to study the effect and mechanism of Chinese compound formula of clearing heat and promoting dieresis in modulating intestinal microbiota dysbiosis, repairing intestinal mucosal barrier and reconstructing intestinal microenvironment. With the combination of metagenomics and metabonomics, the study compare the differences of co-metabolites of intestinal microbiota and host within the healthy people, IBS-D patients with dampness-heat syndrome, to explore the relevance between intestinal flora and host co-metabolites. Furthermore, the experimental study is to clarify the drug targets via C1orf106/ CYTH-1/ARF6 signal pathway.Through the study of association between dampness-heat syndrome in IBS-D and intestinal microbiota, it is of important academic significance to reveal the Chinese theory intension of "homotherapy for heteropathy ".

Detailed Description

Not available

Study Timeline

• Study Start: 2019-04-01
• Status Verified: 2019-08
• Study First Submitted: 2020-01-15
• Study First Submitted QC: 2020-03-13
• Last Update Submitted: 2020-03-13
• Study First Posted: 2020-03-18
• Last Update Posted: 2020-03-18
• Primary Completion: 2020-04-01
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. It meets the diagnostic criteria of diarrhea-predominant irritable boewl syndrome and meets the diagnostic criteria for damp-heat syndrome.
2. Age between 18 and 70 years old.
3. Not taking antibiotics, steroids and other hormones, Chinese herbal preparations in the past week (including) Probiotics such as oral and intravenous), microecological preparations or yogurt.
4. The subject informed and voluntarily signed the informed consent form. ;
5. Have a certain reading ability

Exclusion Criteria

1. Patients with severe organ, liver, kidney and other major organ diseases, hematopoietic system, nervous system or mental illness;
2. combined with other digestive systemic lesions (such as peptic ulcer), or systemic diseases affecting digestive tract motility (eg hyperthyroidism, diabetes);
3. Those who are or need to continue to use drugs that may affect gastrointestinal function (antidiarrheals, antidepressants, anxiolytics, intestinal flora regulators, antibiotics, etc.);
4. Those with a history of allergic reactions to related drugs and a history of severe food allergies.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Experimental group	Modified Gegen Qinlian Decoction	Modified Gegen Qinlian Decoction, Oral, 7.2g per bag, 2 times / day, 30 minutes before breakfast and dinner
Control group	Modified Gegen Qinlian Decoction	Bifico(Bifidobacterium triple viable capsule), orally，2 capsules/time, 2 days/time.

Primary Outcome Measures

Name	Time	Method
IBS symptom severity (IBS-SSS)scale	Change from Baseline disease activity at 4weeks	The IBS-SSS scale is scored from five aspects: the degree of abdominal pain, the frequency of abdominal pain, the degree of bloating, the degree of defecation satisfaction, and the impact on life.Each score is 0-100 points, and the total score is IBS-SSS scores from the degree of abdominal pain, the frequency of abdominal pain, the degree of abdominal distention, the satisfaction of defecation and the impact on life. Each score is 0-100, and the total score is 0-500. The higher the score, the more serious the disease is.
The Clinical Global Impression of severity Scale ( CGI-S)	4 weeks

Secondary Outcome Measures

Name	Time	Method
Bristol Stool Form Scale	4 weeks
PRO scale	4 weeks
The scores of TCM(Traditional Chinese Medicine) syndrome	4 weeks
The short form 36 (SF-36) health survey questionnaire	4 weeks

Trial Locations

Locations (1)

Xiyuanhospital; 🇨🇳 Beijing, Beijing, China